Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial.

M J Pekka Raatikainen, Antti Hakalahti, Paavo Uusimaa, Jens Cosedis Nielsen, Arne Johannessen, Gerhard Hindricks, Håkan Walfridsson, Steen Pehrson, Anders Englund, Juha Hartikainen, Ole Kongstad Rasmussen, Leif Spange Mortensen, Peter Steen Hansen

Research output: Contribution to journalArticlepeer-review

Abstract

The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) is a randomized trial comparing radiofrequency catheter ablation (RFA) to antiarrhythmic drugs (AADs) as first-line treatment of paroxysmal atrial fibrillation (PAF). In order to eliminate the clouding effect of crossover we performed an on-treatment analysis of the data.
Original languageEnglish
Pages (from-to)108-114
JournalInternational Journal of Cardiology
Volume198
DOIs
Publication statusPublished - 2015

Subject classification (UKÄ)

  • Cardiac and Cardiovascular Systems

Fingerprint

Dive into the research topics of 'Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial.'. Together they form a unique fingerprint.

Cite this